LB Pharma Reports Q3 2026 Financials & Appoints New Leadership
LB Pharma reported Q3 2026 financial results, appointing Dr. Susan Kozauer and Joe Miller to corporate leadership positions and provided guidance on the clinical development of its lead drug candidate.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed